Rocket-Like Microneedle Patch for Sustained Hormone Therapy in Prostate Cancer
ACS Biomaterials Science & Engineering · 11.08.2025 · 11 (8) · 4830-4843
DOI: 10.1021/acsbiomaterials.5c00127 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 18.07.2025. Verfasst von Ying-Tzu Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan 33305, Taiwan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Anilides, Nitriles, Tosyl Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Memorial Hospital, National Science and Technology Council.
Abstract (Originalsprache)
Prostate cancer (PCa) remains a significant global health challenge, necessitating the development of advanced therapeutic strategies. This study introduces a rocket-like microneedle patch (RLMNP) as a dual-layer drug delivery system for sustained hormone therapy in PCa. RLMNP integrates a rapid-release layer, employing the pH-responsive zeolitic imidazolate framework-8 (ZIF-8) to encapsulate bicalutamide (CDX), and a sustained-release layer comprising an alginate-tyramine (Alg-Tyr) hydrogel loaded with goserelin. The dual mechanism synergistically targets PCa by blocking androgen receptor signaling and suppressing androgen synthesis. RLMNP demonstrates robust mechanical properties, efficient skin penetration, and controlled drug release profiles. In vivo studies highlight its remarkable efficacy in reducing tumor volume, extending survival (from 34 to 46 days), and mitigating side effects in PCa models. Furthermore, this painless, self-administered platform addresses key limitations of current hormone therapies, including low patient compliance and treatment-associated discomfort. By combining state-of-the-art microneedle technology and a dual-action therapeutic approach, RLMNP establishes a promising paradigm for PCa management. This innovation not only improves therapeutic outcomes but also sets the stage for broader applications of microneedle-based transdermal drug delivery in oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan 33305, Taiwan.
- Department of Biomedical Engineering, National Cheng Kung University, Tainan 70101, Taiwan.
- Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
- Division of Urology, Department of Surgery, Chang Gung Memorial Hospital at Linkou Branch, Taoyuan 33305, Taiwan.
- School of Medicine, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
- Graduate Institute of Clinical Medical Science, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
ORCID-Profile: Hung-Wei Yang
Förderung
- Chang Gung Memorial Hospital
- National Science and Technology Council
Zitieren
APA
Chen, Y. T., Chen, K. T., Yu, K. J., Pang, S. T., & Yang, H. W. (2025). Rocket-Like Microneedle Patch for Sustained Hormone Therapy in Prostate Cancer. ACS Biomaterials Science & Engineering, 11(8), 4830-4843. https://doi.org/10.1021/acsbiomaterials.5c00127
Vancouver
Chen YT, Chen KT, Yu KJ, Pang ST, Yang HW. Rocket-Like Microneedle Patch for Sustained Hormone Therapy in Prostate Cancer. ACS Biomaterials Science & Engineering. 2025;11(8):4830-4843. doi:10.1021/acsbiomaterials.5c00127
BibTeX
@article{Chen2025,
author = {Chen, Ying-Tzu and Chen, Kuan-Ta and Yu, Kai-Jie and Pang, See-Tong and Yang, Hung-Wei},
title = {Rocket-Like Microneedle Patch for Sustained Hormone Therapy in Prostate Cancer},
journal = {ACS Biomaterials Science & Engineering},
year = {2025},
volume = {11},
number = {8},
pages = {4830--4843},
doi = {10.1021/acsbiomaterials.5c00127}
}
EUVIMED